PART II 2 emerging_1k-123122.htm ANNUAL REPORT

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 1-K

ANNUAL REPORT

 

ANNUAL REPORT PURSUANT TO REGULATION A OF THE SECURITIES ACT OF 1933

 

For the fiscal year ended December 31, 2022

 

Emerging Fuels Technology, Inc.

(Exact name of issuer as specified in its charter)

 

Commission File No. 024-11598

 

     
Oklahoma   27-3842479 
(State or other jurisdiction of incorporation or
organization)		   (I.R.S. Employer Identification No.)
     

6024 S. 116th East Avenue

Tulsa, Oklahoma 

  

 

74146

(Address of principal executive offices)   (Zip Code)

 

  918-286-6802  
  Issuer’s telephone number, including area code  

 

Non-Voting Common Stock
(Title of each class of securities issued pursuant to Regulation A)

 

 

 

 

 

 

   

 

 

In this Annual Report on Form 1-K (the “Report”), the terms EFT,” “the Company,” “we,” and “us” refer to Emerging Fuels Technology Inc.

 

THIS REPORT MAY CONTAIN FORWARD-LOOKING STATEMENTS AND INFORMATION RELATING TO, AMONG OTHER THINGS, THE COMPANY, ITS BUSINESS PLAN AND STRATEGY, AND ITS INDUSTRY. THESE FORWARD-LOOKING STATEMENTS ARE BASED ON THE BELIEFS OF, ASSUMPTIONS MADE BY, AND INFORMATION CURRENTLY AVAILABLE TO THE COMPANY’S MANAGEMENT. WHEN USED IN THIS REPORT, THE WORDS “ESTIMATE,” “PROJECT,” “BELIEVE,” “ANTICIPATE,” “INTEND,” “EXPECT” AND SIMILAR EXPRESSIONS ARE INTENDED TO IDENTIFY FORWARD-LOOKING STATEMENTS, WHICH CONSTITUTE FORWARD LOOKING STATEMENTS. THESE STATEMENTS REFLECT MANAGEMENT’S CURRENT VIEWS WITH RESPECT TO FUTURE EVENTS AND ARE SUBJECT TO RISKS AND UNCERTAINTIES THAT COULD CAUSE THE COMPANY’S ACTUAL RESULTS TO DIFFER MATERIALLY FROM THOSE CONTAINED IN THE FORWARD-LOOKING STATEMENTS. INVESTORS ARE CAUTIONED NOT TO PLACE UNDUE RELIANCE ON THESE FORWARD-LOOKING STATEMENTS, WHICH SPEAK ONLY AS OF THE DATE ON WHICH THEY ARE MADE. THE COMPANY DOES NOT UNDERTAKE ANY OBLIGATION TO REVISE OR UPDATE THESE FORWARD-LOOKING STATEMENTS TO REFLECT EVENTS OR CIRCUMSTANCES AFTER SUCH DATE OR TO REFLECT THE OCCURRENCE OF UNANTICIPATED EVENTS.  

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 i 

 

 

Item 1. Business

 

Overview

 

EFT’s mission is to license its proprietary technology for the production of transportation fuels and specialty products from synthesis gas made from any carbonaceous material, including, but not limited to, biomass, biogas, natural gas, MSW, and CO2. EFT also seeks to expand its business model to build own and operate plants using its technology in small pre-engineered plants to convert biogas and natural gas into fuels and chemicals.

 

EFT was initially formed as a limited liability company under the laws of the State of Oklahoma on November 26, 2007 and was converted to a corporation on October 28, 2010.

 

Principal Products and Services

 

EFT has a research and development facility in Tulsa, Oklahoma and a growing patent portfolio with revenue from contract research, license fees and catalyst sales from multiple licensed projects at various stages of development. EFT is focused on using its technology to profitably turn waste sources of carbon into drop-in fuels and chemicals that greatly reduce GHG emissions.

 

The Company

 

  · sells Fischer-Tropsch catalyst,

 

  · provides technology license agreements,

 

  · performs lab and engineering services, and

 

  · plans to build, own and operate BioGTL and Flarebuster plants utilizing our developed technology.

 

In general, technology license agreements with clients of the Company provide a license agreement for the use of our intellectual property and catalyst technology, over which the Company holds a significant number of patents.

 

Current Product and Services Provided to Clients

 

The Company’s licensing agreements provide for the transfer of licensing rights to proprietary technology, which is considered functional intellectual property. The licensing agreements provide for a prepaid royalty along with ongoing royalties based on output. The prepaid royalty is recognized upon execution of the licensing agreement or based on the timeline specified in the agreement. Typically, the licensing agreements contain a process guarantee to the licensee, which provides that the Company guarantees the output of 100% of the plant design capacity as long as the licensee satisfies certain operational requirements. Failure to achieve the guaranteed output may require the Company to repay a portion of the prepaid royalty based on the percent of design capacity achieved.

 

As such, the Company defers recognition of a portion of the prepaid royalty until resolution of the process guarantee. The revenue generated by sales of the catalyst is based on a mark-up of the catalyst costs paid to approved catalyst vendors and recognized as obligations are satisfied by those vendors. Revenue from lab and engineering services is earned on a time and materials or percent complete basis and is recognized as the work is performed. Consideration received prior to satisfying the related performance obligations is deferred and revenue will be recognized when the obligations have been met.

 

 

 

 1 

 

 

Revenue from the Building, Owning and Operating of Plants

 

EFT believes that substantial growth is achievable by using its technology to build, own and operate renewable fuels and chemical plants, solely or in partnership with others in standardized technology configurations. These configurations are:

 

(1) BioGTL - a very small 75-100 barrel per day (BPD) plant that produces renewable diesel or jet fuel from biogas feedstocks. The BioGTL plant is designed to utilize waste gases from landfills, wastewater treatment plants or agricultural digesters. The total resource base in the United States alone is estimated to be large enough to support over 2,000 BioGTL plants.
   
(2) FlareBuster is a 500 BPD plant designed for conversion of flared natural gas feed with greatly reduced GHG emissions. The FlareBuster can also be configured to make higher value products like solvents and lubricants from flared, stranded or otherwise compromised natural gas.

 

These products align with the world’s green energy initiatives by significantly reducing GHG emissions.

 

Market

 

The Company is participating in two distinct markets that use products made from its technology: Renewable fuels and flare mitigation. In both markets, the Company’s technology is focused on reducing the total GHG produced from it in the production of synthetic fuels compared to the production of conventional fossil fuels.

 

At least 64 countries around the world have established targets or mandates for renewable fuels.1 The Company is primarily focused on making renewable fuels for the U.S. market. Renewable fuels made in other countries can be imported into the United States and receive the benefits that are described below. The Company is also focused on making renewable fuels that comply with the California LCFS.

 

Renewable Fuels Standard (RFS) in the United States

 

Congress created the renewable fuel standard (“RFS”) program to reduce greenhouse gas emissions and expand the nation’s renewable fuels sector while reducing reliance on imported oil. This program was authorized under the Energy Policy Act of 2005 and expanded under the Energy Independence and Security Act of 2007. (For more information see https://www.epa.gov/renewable-fuel-standard-program/ )

 

Program Structure

 

The RFS program was created under the Energy Policy Act of 2005, which amended the Clean Air Act (“CAA”). The Energy Independence and Security Act of 2007 (“EISA”) further amended the CAA by expanding the RFS program. The Environmental Protection Agency (“EPA”) implements the program in consultation with U.S. Department of Agriculture and the Department of Energy.

 

The RFS program is a national policy that requires a certain volume of renewable fuel to replace or reduce the quantity of petroleum-based transportation fuel, heating oil or jet fuel. The four renewable fuel categories under the RFS are:

 

  · Biomass-based diesel
  · Cellulosic biofuel (Biogas has been determined by the EPA to be “Cellulosic making the Company’s renewable fuels made from biogas qualify as Cellulosic)
  · Advanced biofuel
  · Total renewable fuel

 

____________

1  https://www.biofuelsdigest.com/bdigest/2016/01/03/biofuels-mandates-around-the-world-2016/

 2 

 

 

The 2007 enactment of EISA significantly increased the size of the program and included key changes, including:

 

  · Boosting the long-term goals to 36 billion gallons of renewable fuel
  · Extending yearly volume requirements out to 2022 and beyond
  · Adding explicit definitions for renewable fuels to qualify (e.g., renewable biomass, GHG emissions)
  · Creating grandfathering allowances for volumes from certain existing facilities
  · Including specific types of waiver authorities

 

Volume Standards as Set Forth in EISA
Year Cellulosic Biofuel Biomass-Based Diesel Advanced Biofuel Total Renewable Fuel "Conventional" Biofuel
2018 7.0 * 11.0 26.0 15.0
2019 8.5 * 13.0 28.0 15.0
2020 10.5 * 15.0 30.0 15.0
2021 13.5 * 18.0 33.0 15.0
2022 16.0 * 21.0 36.0 15.0

*statute sets 1 billion gallons minimum, but EPA may raise requirement

 

Note: There is no statutory volume requirement for "conventional" biofuel. The conventional volumes in the table are calculated (total - advanced) and are certain biofuels that do not qualify as advanced. 

 

The Clean Air Act provides EPA authority to adjust cellulosic, advanced and total volumes set by Congress as part of the annual rule process.

 

The statute also contains a general waiver authority that allows the Administrator to waive the RFS volumes, in whole or in part, based on a determination that implementation of the program is causing severe economic or environmental harm, or based on inadequate domestic supply.

 

Fuel Pathways

 

For a fuel to qualify as a renewable fuel under the RFS program, EPA must determine that the fuel qualifies under the statute and regulations. Among other requirements, fuels must achieve a reduction in GHG emissions as compared to a 2005 petroleum baseline.

 

EPA has approved fuel pathways under the RFS program under all four categories of renewable fuel. Advanced pathways already approved include ethanol made from sugarcane; jet fuel made from camelina; cellulosic ethanol made from corn stover; compressed natural gas from municipal wastewater treatment facility digesters; and others.

 

Biomass-based diesel must meet a 50% lifecycle GHG reduction. Cellulosic biofuel must be produced from cellulose, hemicellulose, or lignin feedstock and must meet a 60% lifecycle GHG reduction (biogas has been certified as a cellulosic feedstock). Advanced biofuel can be produced from qualifying renewable biomass (except corn starch) and must meet a 50% GHG reduction.

 

Renewable (or conventional) fuel typically refers to ethanol derived from corn starch and must meet a 20% lifecycle GHG reduction threshold.

 

 

 

 3 

 

 

Lifecycle GHG reduction comparisons are based on a 2005 petroleum baseline as mandated by EISA. Biofuel facilities (domestic and foreign) that were producing fuel prior to enactment of EISA in 2007 are “grandfathered” under the statute, meaning these facilities are not required to meet the GHG reductions.

 

EPA continues to review and approve new pathways, including for fuels made with advanced technologies or with new feedstocks. Certain biofuels are similar enough to gasoline or diesel that they do not have to be blended, but can be simply “dropped in” to existing petroleum-based fuels. These drop-in compatible biofuels directly replace petroleum-based fuels and hold particular promise for the future.

 

Program Compliance Basics – Renewable Identification Numbers

 

Obligated parties under the RFS program are refiners or importers of gasoline or diesel fuel. Compliance is achieved by blending renewable fuels into transportation fuel, or by obtaining credits (called “Renewable Identification Numbers”, or RINs) to meet an EPA-specified Renewable Volume Obligation (RVO).

 

EPA calculates and establishes RVOs every year through rulemaking, based on the CAA volume requirements and projections of gasoline and diesel production for the coming year. The standards are converted into a percentage and obligated parties must demonstrate compliance annually.

 

Each fuel type is assigned a “D-code” – a code that identifies the renewable fuel type – based on the feedstock used, fuel type produced, energy inputs and GHG reduction thresholds, among other requirements. The four categories of renewable fuel have the following assigned D-codes:

Cellulosic biofuel is assigned a D-code of 3 (e.g., cellulosic biofuel) or D-code of 7 (cellulosic diesel and jet).

 

The Company expects the RINs generated by its fuels to be certified as D3 or D7.

 

Biomass-based diesel is assigned a D-code of 4.

 

Advanced biofuel is assigned a D-code of 5.

 

Renewable fuel (non-advanced/conventional biofuel) is assigned a D-code of 6 (grandfathered fuels are also assigned a D-code of 6).

 

“Renewable identification numbers” or RINs are the credits that obligated parties use to demonstrate compliance with the standard. Obligated parties must obtain sufficient RINs for each category in order to demonstrate compliance with the annual standard.

 

More information on RINs:

 

RINs are generated when a producer makes a gallon of renewable fuel. One gallon of ethanol generates one RIN. RINs for other fuels are based on the btu content of the fuel compared to the btu content of ethanol. One gallon of renewable diesel made from biogas generates 1.7 D7 RINs because of its higher btu content. One gallon of renewable jet fuel from biogas generates 1.6 D7 RINs. One gallon of gasoline blendstock (naphtha) made from biogas generates 1.45 D3 RINs. The calculations and classifications must be confirmed by the EPA before RINs are issued.

 

At the end of the compliance year, obligated parties use RINs to demonstrate compliance.

 

RINs can be traded between parties. Obligated parties can buy gallons of renewable fuel with RINs attached. They can also buy RINs on the market.

 

Obligated parties can carry over unused RINs between compliance years. They may carry a compliance deficit into the next year. This deficit must be made up the following year.

 

 

 

 4 

 

 

The RFS program’s four renewable fuel standards are nested within each other. In other words, the fuel with a higher GHG reduction threshold can be used to meet the standards for a lower GHG reduction threshold. For example, fuels or RINs for advanced biofuel (i.e., cellulosic, biodiesel or sugarcane ethanol) can be used to meet the total renewable fuel standards (i.e., corn ethanol).

 

The table below shows which RIN type and D-code can be used to demonstrate compliance with the four categories of fuel that together comprise an obligated parties’ renewable volume obligation (RVO): 

 

D-Code Cellulosic Biofuel Biomass-Based Diesel Advanced Biofuel Total Renewable Fuel
3 X   X X
4   X X X
5     X X
6       X
7 X   X X

 

For cellulosic standards, an additional flexibility is provided. Cellulosic waiver credits (CWC) are offered by EPA at a price determined by formula in the statute. Obligated parties have the option of purchasing CWCs plus an advanced RIN in lieu of blending cellulosic biofuel or obtaining a cellulosic RIN.

 

Cellulosic Waiver Credits under the Renewable Fuel Standard Program

 

Cellulosic fuels have not yet been produced in sufficient amounts to satisfy the volume levels listed in the Clean Air Act. The law allows EPA to reduce the required volume of cellulosic biofuel through waiver. EPA has used this waiver provision each year since 2010.

 

Under this provision, EPA may reduce the volume of cellulosic RINs required by instead offering obligated parties cellulosic waiver credits (CWCs) at levels no greater than the reduced cellulosic biofuel standard. These waiver credits may be purchased at prices EPA sets using the methodology in the statute. Credits cannot not be traded or banked for future use. They must be used to meet the cellulosic biofuel standard for the year that they are offered.

RIN trading and price information can be found on the EPA website.2

 

The California LCFS Program

 

The California Low Carbon Fuel Standard is a market-based program that focuses specifically on reducing carbon intensity of fuels used within California. It was created in 2011 by the California Air Resources Board as part of several AB32 measures to reduce greenhouse gas emissions throughout the state 20% by 2030 and 80% by 2050.

 

The LCFS program provides several credit generation opportunities to incent production and use of low carbon fuels, increasing attainment of AB32 goals. Below are three ways to generate credits under the LFCS program:

 

  · Fuel pathway-based crediting: Low-carbon fuels in the California fuel pool can generate credits based on emissions reduced compared to the established CI baseline. These credits incent developers to bring more clean fuel options to California.

 

  · Project-based crediting: This category includes projects to reduce emissions across the petroleum supply chain as well as carbon capture and sequestration (CCS) using direct air capture.

 

  · Zero-emissions vehicle infrastructure (Capacity-based) crediting: Installation of hydrogen and DC fast charging electric infrastructure can generate credits based on capacity, then credited in accordance to fuel pathways. Infrastructure for zero emission vehicles, especially medium and heavy duty, is limited; these credits compensate for such limited infrastructure.

 

 

____________

2 https://www.energy.gov/sites/prod/files/2019/08/f65/Natural%20Gas%20Flaring%20and%20Venting%20Report.pdf

 5 

 

 

Fuel Pathway-Based Crediting:

 

  · Each LCFS credit represents one metric ton (MT) of Carbon Dioxide reduced. Credits are generated as fuel is consumed within transportation, specifically when the fuel has a CI score lower than the target established by CARB. Fuels with a CI score higher than the CARB target generate deficits. Deficits need to be offset by generating or purchasing LCFS credits.

 

  · Typically, regulated parties (RPs) such as refiners, petroleum importers and wholesalers are the ones generating credits and/or deficits. Alternative fuel producers can opt-into the program as RPs, if they choose to do so. Each RP along the fuel supply chain can either generate LCFS credits or deficits as they bring fuel into the state of California.

 

  · Carbon Intensity (“CI”) is used to measure all greenhouse gas emissions associated with the production, distribution and consumption of a fuel. Each year new CI benchmarks are set to reach LCFS program goals. The CI score is part of the equation to establish the amount of credits or deficits a fuel can generate. Each fuel has a range of CI scores, shown in the graph below. Markers represent the CI score for certified fuel pathways and the length of each bar represents the range of CI scores that may be achieved by each fuel. CI scores are developed based on life cycle analysis methodology, with varying scores due to feedstock types, origin, raw material processing efficiencies and use within transportation. Lower CI scores are most favorable because they are the cleanest solutions and therefore, awarded the highest LCFS credit values.

 

  · RPs that have generated deficits and not enough credits themselves must then find credits to buy and satisfy their required obligation per CARB. Alternative fuel producers, that typically generate more LCFS credits than needed, sell their credits to RPs using the LCFS Credit Banking and Transfer System, which is a CARB-administered platform. Credit owners can only sell to other RP deficit holders, meaning entities not registered by CARB as a regulated party are not allowed to hold LCFS credits.

 

Flare Reduction

 

According to the World Bank, about 150 billion cubic meters (BCM) of gas was released into the atmosphere in 2019 from gas flaring (equal to 5,298 billion cubic feet (“BCF”)/year or 14.5 BCF/day). The United States contributed 17.29 BCM or 11.5% of the total). The CO2 emissions from global flaring is estimated to be 307 million tons, the equivalent of over 60 million Internal Combustion Engine passenger vehicles assuming it is 100% combusted. But flaring it is not 100% efficient. When the harmful effects of the methane that slips by the flares are taken into account, the equivalent number jumps to over 560 million passenger vehicles.

 

All flares vent some portion of methane due to incomplete combustion caused by a variety of factors. This is known as “methane slip.” Methane slip is a significant problem. In countries that flare it is a much bigger contributor to GHG emissions than the CO2 created by the flares. According to the IPCC Fifth Assessment Report, methane has 86 times the Global Warming Potential (GWP) of CO2 (on a mass basis) on a 20-year timescale and 28 times on the 100-year timescale. (Note, the GWP for methane used to be stated as 25. The IPCC Fifth Report has upgraded that estimate to 28.)

 

In most cases in the United States, flaring occurs because there is no economic use for the gas which is produced in association with oil production. The Company believes that its FlareBuster product offers an economical solution for flared gas in many circumstances. Other uses for flared gas include generation of electricity, conversion to LNG, CNG or certain chemicals. The economic viability of any option tends to be site specific. Flaring in the United States is regulated at both the federal and state level.3

 

Competition

 

We are competing on the national and international level with companies who can offer other uses for biogas and flared gas as well as companies who have developed or are developing technologies that produce liquid transportation fuels from these feedstocks and from other renewable feedstocks such as municipal solid waste, biomass, carbon dioxide and other materials.  Competitors have developed similar processes to ours including catalytic chemical reactions turning synthesis gas (carbon monoxide and hydrogen) into fuels (liquid hydrocarbons, such as diesel or jet fuel) and providing integrated end-to-end processes that convert solid wastes, first to synthesis gas and then to liquid transport fuels.

 

 

____________

3 https://www.energy.gov/sites/prod/files/2019/08/f65/Natural%20Gas%20Flaring%20and%20Venting%20Report.pdf

 6 

 

 

There are several large companies who have Fischer-Tropsch technology but are not considered competition to the Company because the companies have not attempted to pursue small scale plant development (under 10,000 BPD). The oldest is Sasol who operates several large-scale gas-to-liquids plants in South Africa and one in Qatar. Shell also operates a large-scale plant in Qatar and another smaller plant in Bintulu Malaysia. Exxon and Chevron have also developed Fischer-Tropsch technology but have not, to date, commercialized it. Johnson Matthey (in partnership with BP) has licensed one plant, Fulcrum Bioenergy a MSW to Fuels plant located near Reno, Nevada. BP is an investor in Fulcrum.

 

The World Bank, under its Global Gas Flaring Reduction program has, for several years, published data on companies developing and/or offering small scale gas to liquids technology.4 The most recent version of that report includes several companies that claim to have commercially ready technology, including EFT. Others included are Velocys, Greyrock, Bluescape Clean Fuels (formerly Primus Green Energy), CompactGTL, Infra Technology, GasTechno, Topsoe/MPS, Maverick Synfuels, AUM Energy and BGTL, along with several others who are still in development. Some of these companies have considerably more financial resources than the Company. The technologies and the type and quality of the products made vary widely.

 

Other uses for biogas and flared gas are also potential competitors to the Company. These other uses may include, but are not limited to, production of electricity, conversion to LNG or CNG, conversion to methanol, conversion to chemicals and, in the case of biogas, clean up and use as renewable natural gas. Each opportunity for feedstock tends to be evaluated based on which available option will provide the best economic solution at that specific location.

 

Raw Materials/Suppliers

 

Porocel Industries and Eurosupport are the two manufacturers that manufacture our proprietary catalyst based upon our specifications. For laboratory work the primary raw materials are gases supplied by Airgas that represents more than 5% of our laboratory expenses. Raw materials are ordered and purchased by our licensees while we coordinate ordering processes.

 

Employees

 

The Company employs a staff of seven full-time and two part-time employees.

 

Regulation

 

Building commercial plants with our technology is subject to several different environmental laws, regulations and permitting requirements administered by the EPA and the states where our facilities may be located, including Clean Air Act requirements as the production of renewable fuels involves the emission of various airborne pollutants.

 

Intellectual Property

 

We currently have 17 issued patents with several more pending and in development. Issued patents include 10,836,963; 10,836,634; 11,220,473; 10,815,165; 10,662,382; 10,434,506; 10,434,484; 10,329,492; 9,677,005; 9,676,678; 9,358,526; 9,321,641; 9,180,436; 9,062,257; 9,034,208; 8,894,939 and 8,202,917.

 

Of the 17 issued patents, 5 are for the Fischer-Tropsch (FT) reactor. The FT reactor and the FT catalyst are at the heart of everything we do. The first three reactor patents (10,836,963; 10,662,382 and 10,434,484) are variations on our preferred reactor type. The variations give us flexibility to design for variables with respect to gas composition that we can encounter in a project.

 

The other two patents (8,894,939 and 8,202,917) are developmental reactor designs. We have no current plans for these designs. They could be useful in the future or we could license them to others. The FT catalyst patents (9,358,526 and 9,180,436) are used in everything we plan to do. The Catalyst activation/regeneration patent (10,434,506) is used with our FT catalyst in everything we do.

 

 

____________

4 https://www.worldbank.org/en/programs/gasflaringreduction

 7 

 

 

The FT shutdown procedure patent (10,329,492) is used in everything we do. The tail gas recycle patent (9,062,257) helps increase yields and is useful in everything we do.

 

Litigation

 

In the normal course of business, the Company may be involved in legal proceedings, claims and assessments arising in the ordinary course of business. Such matters are subject to many uncertainties, and outcomes are not predictable with assurance. In the opinion of management, the ultimate disposition of these matters will not have a material adverse effect on the Company’s financial position or results of operations.

 

The Company’s Property

 

The Company leases its Tulsa, Oklahoma facility under a lease agreement and the landlord has granted the Company a thirty day right of first refusal to purchase the property on terms equal or better than terms offered by any purchaser of the facility .

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 8 

 

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

You should read the following discussion and analysis of our financial condition and results of our operations together with our financial statements and related notes included in this 1Report. This discussion contains forward-looking statements reflecting our current expectations that involve risks and uncertainties. Actual results and the timing of events may differ materially from those contained in these forward-looking statements due to a number of factors, including those discussed in the section entitled “Risk Factors” in the Company’s Offering Statement on Form 1-A and elsewhere in this Report.

 

Overview

 

Emerging Fuels Technology Inc. is an energy technology company with a headquarters, research and development, and lab operating facility located in Tulsa, Oklahoma. The Company has a growing patent portfolio with historic operating revenue from laboratory and engineering services, contract research, technology license fees and catalyst sales from multiple licensed projects at various stages of development. The Company is planning to expand its business by using its technology to build, own and operate facilities to profitably turn waste sources of carbon into drop-in compatible fuels and chemicals that greatly reduce GHG emissions.

 

There are multiple paths for producing renewable fuels and chemicals with the Company’s technology. Generally, this conversion takes three steps. Step one is conversion of renewable feedstocks into synthesis gas comprising Carbon Monoxide (CO) and Hydrogen (H2) which is sourced from multiple technology providers in the market. For steps two and three, the Company has developed technology which includes Fischer Tropsch synthesis to make synthetic crude oil and upgrading of the synthetic crude into finished products. This technology has taken years to develop, perfect and position for commercialization and the Company is one of a handful of companies with commercially viable technology.

 

The Company has developed two new configurations of its technology that significantly expands its commercial opportunities. These configurations are: (1) BioGTL, a small (typically 75-100 BPD) plant that produces renewable diesel or jet fuel from biogas feedstocks and (2) FlareBuster, a 500 BPD plant designed for conversion of flared natural gas feed into alternative transportation fuels which greatly reduces GHG emissions when compared to flaring. The Company believes that since both configurations are highly integrated and modular, the capex is reduced and because of the size, the installation schedule is shorter, compared to projects based on solid renewable feedstocks. The FlareBuster can also be configured to make higher value products like solvents and lubricants from flared, stranded or otherwise compromised natural gas. These products align with the world’s green energy initiatives by significantly reducing GHG emissions.

 

Currently our licensing business includes clients with commercial licensed plants in start-up or under construction, and others are in detailed design and are positioning to be the technology provider for a growing number of renewable fuels projects. The Company believes that substantial growth is achievable by using its BioGTL and FlareBuster technology to build, own and operate renewable fuels and chemical plants, solely or in partnership with others. The Company is raising funds to implement a business plan to expand our renewable/alternative fuels business.

 

Historically our operating results are most influenced by our revenues from technology license fees and catalyst sales. Technology license and catalyst sales are high margin and can also drive laboratory and engineering services. A large portion of our revenue is generated from a small number of clients with relatively large technology license fees and catalyst sales. The timing of these large technology license fees and catalyst transactions are often unpredictable and make revenues and profits fluctuate. For instance, revenue for licensing, which includes catalyst income, was $1,675,000 for licensing and catalyst income from one client in 2022 compared to $993,000 for licensing and catalyst income from four clients in 2021.

 

 

 

 9 

 

 

Critical Accounting Policies and Estimates

 

The Management Discussion and Analysis of Financial Condition and Results of Operations is based upon our financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”). The preparation of these financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reported period. We base our estimates and assumptions on historical experiences and various other factors that are believed to be reasonable under the circumstances. These estimates and assumptions are evaluated on an ongoing basis. Actual results may differ from previously estimated amounts due to different assumptions or conditions. The following critical accounting policies which involve significant judgements and estimates, are used in the preparation of our financial statements:

 

Revenue Recognition

 

The Company generates revenue through contracts in which it (i) sells Fischer-Tropsch and ammonia oxidation catalysts, (ii) provides technology license agreements and (iii) performs lab and engineering services. In general, contracts with the Company provide a license agreement for the use of its intellectual property and catalyst technology, over which the Company holds a significant number of patents. The majority of the Company’s revenue is derived from a small number of significant commercial customers. Revenue is recognized when the Company satisfies a performance obligation by transferring promised goods or services to a customer. Revenue from goods or services is measured as the amount of consideration expected to be received in exchange for the goods and services delivered.

 

The Company’s licensing agreements provide for the transfer of licensing rights to proprietary technology, which is considered functional intellectual property. The licensing agreements provide for a prepaid royalty along with ongoing royalties based on output. The prepaid royalty is recognized upon execution of the licensing agreement or based on the timeline specified in the agreement. Typically, the licensing agreements contain a process guarantee to the licensee, which provides that the Company guarantees the output of 100% of the plant design capacity as long as the licensee satisfies certain operational requirements. Failure to achieve the guaranteed output may require the Company to repay a portion of the prepaid royalty based on the percent of design capacity achieved. As such, the Company defers recognition of a portion of the prepaid royalty until resolution of the process guarantee. The revenue generated by sales of the catalyst is based on a mark-up of the catalyst costs paid to approved catalyst vendors and recognized as obligations are satisfied by those vendors. During 2021, the Company began selling ammonia oxidation catalyst to customers. The Company acquires this catalyst from a vendor and recognizes revenue and costs of the catalyst and revenue sharing marketing costs upon delivery to the customer. Revenue from lab and engineering services is earned on a time and materials or percent complete basis and is recognized as the work is performed. Consideration received prior to satisfying the related performance or delivery obligations is deferred and revenue will be recognized when the obligations have been met.

 

Accounts Receivable and Bad Debts

 

The Company has receivables that arise from its customer agreements. Losses from uncollectible receivables are accrued when it is probable that a receivable is impaired, and the amount of the loss can be reasonably estimated. During the year ending December 31, 2021, management determined that these conditions existed and continue to exist and, as such, an allowance for doubtful accounts was established in the amount of $263,310. This amount is related to services provided to our licensee in Trinidad and Tobago. During 2021, the licensee’s gas to liquid fuels plant experienced an adverse event during start-up that involved part of the plant not related to our technology license. The plant has been down for repairs and improvements, and it is not clear if sufficient funding will be obtained to resume operations or pay our receivables.

 

 

 

 10 

 

 

Long-Lived Assets

 

The Company assesses all long-lived assets, including property and equipment, for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Factors that are considered in deciding when to perform an impairment review include significant under-performance of the business in relation to expectations, significant negative industry or economic trends, and significant changes or planned changes in the use of the assets.

 

Property and Equipment

 

Property and equipment are recorded at cost and depreciated over the estimated useful life. When retired or otherwise disposed of, the related cost and accumulated depreciation are cleared from the respective accounts and the net difference, less any amount realized from the disposition, is reflected in income.

 

Patents and Trademarks

 

Patents and trademarks are recorded at cost less accumulated amortization and impairment losses. Amortization is charged on a straight-line basis over the lesser of 20 years from the date of filing or 17 years from the date of issuance, which is the estimated useful economic life. Useful lives are reviewed annually and adjusted if appropriate.

 

Operating Lease Asset and Liability

 

The Company adopted ASU No. 2016-02 effective January 1, 2022 using the modified retrospective approach which establishes new accounting and disclosure requirements for leases. This ASU requires lessees to classify most leases as either finance or operating leases and to initially recognize a lease liability and right-of-use asset.

 

Income Taxes

 

Deferred income taxes are provided to reflect the impact of temporary differences between the amounts of assets and liabilities for financial reporting purposes and such amounts as measured by tax laws and regulations. Tax credits are recognized as a reduction to income taxes in the year the credits are earned.

 

Tax positions are recognized only when it is more likely than not (likelihood of greater than 50%) that the position would be sustained upon examination based solely on the technical merits of the position. Tax positions that meet the more likely than not threshold are measured using a probability-weighted approach as the largest amount of tax benefit that is greater than 50% likely of being realized upon settlement.

 

Stock-Based Compensation

 

The Company measures compensation cost for stock option awards at fair value and recognizes compensation over the service period for awards expected to vest. The fair value of each option grant is estimated on the date of grant using the Black-Scholes pricing model and straight-line amortization of compensation expense over the requisite service period of the grant. The determination of fair value using the Black-Scholes model requires a number of complex and subjective variables. Key assumptions in the Black-Scholes pricing model include the market value and exercise price of the options, the expected term, expected volatility, the risk-free interest rate, and estimated forfeitures.

 

 

 

 11 

 

 

Results of Operations

 

Year Ended December 31, 2022 Compared to Year ended December 31, 2021

 

Revenue

 

The following table summarizes revenues and the percent change from the prior year:

 

   For the Years Ended December 31, 
   2022   2021   % Change 
Revenue               
Lab and licensing  $1,746,950   $1,260,087    39% 
Engineering and technical   1,170,350    396,335    195% 
Other   88,208    26,392    234% 
Total revenue  $3,005,508   $1,682,814    79% 

 

Total revenues in 2022 increased $1,322,694 or 79% when compared to the prior year. Revenue for licensing, which includes catalyst income, was $1,675,00 from one client during 2022 as the Company entered into agreements with a buyer, and the bankruptcy trustee for the sale of EFT proprietary catalyst owned by a former shareholder and customer that liquidated its business under Chapter 7 of the U.S. Bankruptcy Code in 2020. In connection with this liquidation, EFT agreed to assist with identifying buyers for that catalyst and split the proceeds with the bankruptcy trustee. During 2022, the Company arranged with the bankruptcy trustee for the sale of catalyst for a sales price of $4.2 million and after payments to suppliers of $850,000, and the shared proceeds with the bankruptcy trustee, the Company recognized income of $1,625,000 for proceeds received when the catalyst was delivered to the buyer. In 2021, revenue for licensing was $993,000 for licensing and catalyst income from four clients, including sales of $510,000 to two ammonia oxidation catalyst customers. Lab services income declined $195,137 or 73% in 2022 when compared to 2021 due to lab resources being shifted to support engineering activities during 2022. Engineering and technical revenues increased $774,015 or 195% in 2022 when compared to the prior year due primarily to increased demand for our technology reflected in revenues provided by engineering services provided for pilot demonstration facilities and engineering for Front End Engineering Design (FEED) study projects in 2022. Other revenue increased $61,816 or 234% in 2022 compared with 2021 primarily due to $71,981 for Employee Retention Credits received in 2022 offset by decreased recoverable expenses due to lower lab activity in 2022 when compared to 2021.

 

Lab and Engineering Costs

 

The following table summarizes lab and engineering costs and the percent change from the prior year:

 

   For the Years Ended December 31, 
   2022   2021   % Change 
Lab and Engineering Costs               
Payroll and benefits  $441,651   $436,343    1% 
Subcontracted services   673,685    266,799    153% 
Gas costs   141,745    162,246    -13% 
Catalyst and demo plant cost   335,757    356,189    -6% 
Other   21,054    26,327    -20% 
   $1,613,892   $1,247,904    29% 

 

 

 

 12 

 

 

Lab and engineering costs increased $365,988 or 29% when 2022 is compared with 2021. The increase was primarily attributable to increased subcontracted services for engineering costs of $406,886 or 153% due to supporting engineering costs incurred for FEED studies for clients in 2022. Other lab and engineering costs also included catalyst and demonstration plant cost that decreased $20,432 or 6% when 2022 is compared with 2021. In 2022, cost associated with two demonstration plants for clients was $335,757 and in 2021 cost on the sales of ammonia oxidation catalyst sales incurred $356,189 in costs for the catalyst and revenue sharing for marketing of the catalyst to two customers. Additionally, gas costs declined $20,501 or 13% in 2022 primarily due to the decreased gas required for supporting lab services income activities when compared to the prior year.

 

Operating Expenses

 

The following table summarizes operating expenses and the percent change from the prior year:

 

   For the Years Ended December 31, 
   2022   2021   % Change 
Operating Expenses               
Payroll and benefits  $646,832   $614,242    5% 
Stock-based compensation   –    3,292      
Contract and professional services   452,482    744,731    -39% 
Rent   73,033    71,530    2% 
Utilities   52,915    45,149    17% 
Depreciation and amortization   46,392    43,952    6% 
Provision for bad debt   –    263,310      
Loss on asset impairment   –    8,434      
Other   82,005    85,264    -4% 
Total operating expenses  $1,353,659   $1,879,904    -28% 

 

Operating expenses decreased $526,245 or 28% in 2022 when compared to 2021. This decrease was primarily attributed to decreases in contract and professional services expense of $292,249 and a $263,310 provision for bad debt when compared to the prior year. The majority of the decrease for contract and professional services expense is attributed to expenses associated with the Company’s offering under Regulation A, which included legal, financial preparation and audit, brokerage, and transfer agent service expenses and marketing costs associated with the offering and other fundraising activities. The expenses associated with the initial year’s offering and marketing costs in 2021 declined approximately $270,000 when compared to these costs in 2022 due primarily to a decrease in marketing costs and fewer services required in the second year of the offering. The provision for bad debt is related to services provided to our licensee in Trinidad and Tobago. During 2021, the licensee’s gas to liquid fuels plant experienced an adverse event during start-up that involved part of the plant not related to our technology license. The plant has been down for repairs and improvements, and it is not clear if sufficient funding will be obtained to resume operations or pay our receivables.

 

Other 2021 operating expense charges include stock-based compensation of $3,292 recognized in 2021 as 200,000 performance-based options, issued in 2021 to two members of management, vested based on the completion of certain financing goals. Accordingly, the fair value of those options was recorded as stock-based compensation expense. A loss on asset impairment was recognized in 2021 for the amount of $8,434 for unamortized costs associated with an abandonment of a patent project.

 

 

 

 13 

 

 

Other Income (Expense)

 

The following table summarizes other income (expense) and the percent change from the prior year:

 

   For the Years Ended December 31, 
   2022   2021   % Change 
Other Income (Expense)               
Gain on forgiveness of loan  $    $174,139      
Interest income (expense), net   (89,769)   (37,860)   137% 
Total other Income (expense)  $(89,769)  $136,279    -166% 

 

In response to the potential financial effects resulting from COVID-19 disruptions, the Company applied for a loan through the Paycheck Protection Program (PPP) under the CARES Act. The Company received a loan in January 2021 for $172,600. The loan had an interest at a rate of 1% annually. The Company applied for forgiveness of the entire principal amount, plus accrued interest, with the United States Small Business Administration (SBA) and the SBA granted forgiveness of $174,139 for the loan and all accrued interest in December 2021.

 

On September 3, 2020 the Company entered into a loan authorization and agreement in the amount of $150,000 with the United States SBA, as lender, pursuant to the SBA’s Economic Injury Disaster Loan (EIDL) assistance program in light of the impact of the COVID-19 pandemic on the Company’s business. On August 2, 2021, the Company’s EIDL loan was modified to increase the borrowings under the loan from $150,000 to $500,000.

 

Interest income (expense) was a net interest expense of $89,769 in 2022 compared to a net interest expense of $37,860 in 2021.

 

In August 2021, the Company issued $750,000 of convertible balloon loans (“Convertible Balloon Loans”) . Initially, the notes were due and payable in full on the first anniversary of the execution date and bear interest at 10% per annum. In August 2022, $650,000 of the Convertible Balloon Loans were extended and now are due and payable in full on the second anniversary of the execution date and bear interest at 10% per annum. The remaining convertible notes were converted into 220,000 shares of non-voting common stock. Interest expense on convertible debt was $73,410 in 2022 and $26,596 in 2021 and accretion of debt discounts was $3,177 in 2022 and $1,588 in 2021.

 

Interest expense for the PPP loans was $1,539 in 2021. Interest on the EIDL assistance loan increased to $18,750 in 2022 compared to $10,911 in 2021, primarily due to an additional $350,000 in EIDL proceeds that were received in 2021.

 

Interest income earned from interest bearing deposit accounts was $5,569 in 2022 and $2,774 in 2021.

 

Liquidity and Capital Resources

 

At December 31, 2022, our principal sources of liquidity consisted of cash and cash equivalents of $1,509,041 and accounts receivable, net of reserve, of $125,282. This compares with December 31, 2021 cash and cash equivalents of $1,241,735 and accounts receivable, net of reserve, of $33,745.

 

Net cash provided by operating activities in 2022 was $267,926 compared to net cash used for operating activities in 2021 of $799,462. This improvement of $1,067,388 in cash operating activity in the current year was largely attributed to the decreased net loss of $51,812 in 2022 when compared to a net loss of $1,308,715 in the prior year. The decrease in net loss was attributed to our increased revenues in 2022 of $1,322,694; which was primarily provided by the $1,625,000 in proceeds from the bankruptcy catalyst sale.

 

 

 

 14 

 

 

For the year ended December 31, 2022, the increase in cash of $267,306 was primarily provided by $269,927 from our operating activities. For the prior year ended December 31, 2021, the increase in cash of $436,640 was provided by $1,293,833 from our financing activities offset by $799,462 used for operating activities and $57,731 used for investing activities.

 

In 2022, cash flows provided by operating activities was $267,926 was attributed to increases in accrued expenses for contractual obligations $257,450 and collected fees in advance of services provided resulting in increased deferred revenues of $83,775 offset by other working capital changes.

 

During 2021, cash flows used in operating activities was $799,462. This use from operating activities included a net operating loss of $1,308,715, net of $320,576 in non-cash charges for bad debt, asset impairment, depreciation, amortization, accretion and stock based compensation combined with a $174,139 gain for forgiveness associated with the PPP loan adjustments and resulted in a net use of funds of $1,162,278. This use of funds was partially offset by $362,816 in changes in operating assets and liabilities, including increased deferred revenues from collection on customer contracts in advance of earnings of $457,850 and increased accounts payable of $118,221, primarily attributed to marketing costs associated with the Regulation A offering. These funds provided from operating assets and liabilities were partially offset by other net asset increases of $213,255.

 

Cash used in investing activities for property and equipment purchases and patent and trademark costs were $31,767 in 2022 and $57,731 in 2021.

 

Financing activities during 2022 were from proceeds from non-voting stock sales of $31,147 compared to $21,233 raised in the prior year.

 

Financing activities in 2021 included the Company applying for and receiving pandemic relief assistance loans of $172,600 from the PPP forgivable loans and loan advances of $350,000 from the EIDL assistance program. Borrowings under this EIDL loan bear interest at 3.75% per annum and are secured by a security interest on all of the Company’s assets. At December 31, 2022, the EIDL loan balance was $500,000 and has accrued interest of $31,372. Under this amended loan, the Company is required to make monthly principal and interest payments of $2,534 commencing March 2023. All remaining principal and accrued interest is due and payable September 2050. The loan may be repaid at any time without penalty.

  

Additionally in 2021, the Company issued $750,000 in Convertible Balloon Loans to accredited investors. In August 2022, $650,000 of the Convertible Balloon Loans were extended and now are due and payable in full on the second anniversary of the execution date and bear interest at 10% per annum. Also during 2022, $100,000 of the convertible notes elected to convert principal and interest into 220,000 shares of non-voting common stock shares.

 

The extended notes provide that at any time prior to payment in full of the outstanding principal balance and accrued interest on the maturity date the investor will have the option to (i) receive a balloon payment for the total amount of the investor’s principal amount invested plus interest or (ii) forgive the balloon loan and receive shares of the Company’s Non-Voting Common Stock at a conversion rate of 1 share for each $0.50 of the investor’s principal plus interest. As of December 31, 2022, accrued interest on these notes amounted to $90,006.

 

Furthermore, in connection with the Convertible Balloon Loans, the Company issued the investors 1,500,000 warrants to purchase the Company’s Non-Voting Common Stock at a rate of 1 warrant for each $0.50 of the principal amount of the convertible notes with an exercise price of $0.50 per share and a ten (10)-year term.

 

In August 2021, the Company filed an offering statement on Form 1-A under Regulation A of the Securities Act pursuant to which the Company intends to offer up to 20,833,333 shares of non-voting common stock at a price of $3.60 per share (the “Regulation A Offering”). The offering is a continuous offering that commenced on September 17, 2021 and was requalified on September 19, 2022. Proceeds from this offering were $31,147 and $21,233 in 2022 and 2021, respectively. Our equity offering for non-voting shares was initially delayed to the final quarter of 2021 when poor market conditions contributed to slow market response for Regulation A offerings. Additionally, the complexity of the Company’s marketing message and the uniqueness of being the first renewable energy company to issue a Regulation A offering that was not a wind or solar business may have also contributed to slower acceptance. The Company expects to revise and renew marketing efforts for our offering in 2023 as additional commercial transactions are finalized in 2023.

 

 

 

 15 

 

 

Historically our operating results and liquidity has been tied to our revenues from technology license fees and catalyst sales. Technology license and catalyst sales are high margin and can drive laboratory and engineering services. A large portion of our revenue is generated from a small number of clients with relatively large technology license fees and catalyst sales. The timing of these large technology license fees and catalyst transactions are often unpredictable and make revenues and profits fluctuate. Prior to our current Regulation A Offering, the Company’s most recent capital raise was $3.0 million and occurred in December 2015 and the Company has relied on operating results since that last capital transaction.

 

Although our audited financial statements for the years ended December 31, 2022 and December 31, 2021 were prepared under the assumption that we would continue our operations as a going concern, the report of our independent registered public accounting firm that accompanies our financial statements for the years ended December 31, 2022 and December 31, 2021 contains a going concern qualification in which such firm expressed substantial doubt about our ability to continue as a going concern, based on the financial statements at that time. Specifically, the Company has incurred a net loss for the years ended December 31, 2022 and 2021, may incur additional losses in the future and has incurred cumulative operating losses since inception.

 

Management understands that the negative results are not sustainable. The Company’s ultimate success depends on the outcome of a combination of factors, including the following: (i) successful commercialization of patented technology; (ii) market acceptance and commercial viability of the Company’s technology; and (iii) ability to meet working capital needs. Management believes that there are several positive initiatives that will allow the Company to achieve its goals, including the following: (i) interest in renewable fuels has continued to increase, attributable to higher oil prices and the need for energy security; (ii) the Company has opened discussions with several large companies seeking a strategic partnership; and (iii) the Company has experienced an increased level of inquiries from project developers seeking to license its technology for biomass, municipal solid waste, and biogases to liquid fuels and CO2 to fuels projects. Additionally, the Company continues to pursue additional sources of funding, including raising funds through the issuance of common stock under the Regulation A Offering.

  

Based upon the Company’s current operating plan, management expects that cash at December 31, 2022, in combination with anticipated revenue and additional sources of funding, will be sufficient to fund operations for at least the next 12 months. The Company has evaluated and will continue to evaluate its operating expenses and will concentrate its resources toward successful commercialization of its patented technology. However, there are no assurances that the Company will be successful in implementing its plan and any inability to execute the plan could have a material adverse effect on the business and its operations.

 

Trend Information

 

Interest in renewable fuels has increased dramatically over the past year. Much of this increase can be attributed to higher oil prices and the need for energy security. The Company has opened discussions with several large companies seeking a strategic partnership to develop their resources. We are also seeing a higher level of inquiries from project developers seeking to license our technology for biomass, municipal solid waste, and biogases to liquid fuels and CO2 to fuels projects. We expect this trend to continue for the foreseeable future. Our BioGTL plant design gives the Company another entry into the renewable fuels space. The increased interest in renewable fuels is also causing an increase in activity for our engineering and lab services associated with our licensee projects or potential licensee projects.

  

 

 

 16 

 

 

Item 3. Directors and Officers -

 

The Company’s officers and directors are as follows.

 

Name  Position  Age 

Term of Office (if indefinite

give date appointed)

  Approximate hours per week (if part-time/full-time)
Executive Officers:            
Kenneth L. Agee  President  66  Since 10/29/2010  40
Mark A. Agee  VP Business Development  70  Since 04/29/2014  40
Edwin L. Holcomb Jr.  Chief Accounting Officer  64  Since 07/27/2017  40
             
Directors:            
Kenneth L. Agee  Chairman  66  Since 10/29/2010  4
Edwin L. Holcomb Jr.  Director  64  Since 08/03/2015  4
Katie Marie Werner  Director  46  Since 05/11/2021  1
Raymond Lee Witten  Director  68  10/14/2014-10/04/2016; 04/18/2017 to present  1
Terry Lee Ingle  Director  70  Since 02/28/2012  1
             
Significant Employees:            
Gary Ronald Young  Manager of Laboratory Services  48  Since 01/11/2008  40
James William Engman  Manager of Technical Services  74  Since 01/11/2008  30

 

Kenneth L. Agee, Founder, President and Director, has a background in crude oil refining and natural gas processing. In 1984, he formed Syntroleum Corporation a publicly traded company where he held the position of CEO and did extensive GTL development with several large oil companies between 1990 and 2007. In 2007, Mr. Agee formed EFT where he has worked to establish a growing contract research and technology licensing business while developing novel approaches to FT catalysis, reactor design, process integration and product upgrading that will significantly reduce the construction and operating cost of small, modular plants. Mr. Agee holds a degree in Chemical Engineering from Oklahoma State University and is listed on 26 issued U.S. patents and 3 pending patents. Kenneth Agee is the brother of Mark Agee.

 

Mark A. Agee, VP of Business Development, has spent his entire career growing technology companies, from start-up through IPO, having taken two companies public. Mr. Agee was one of the original investors in Syntroleum, founded by his brother Kenneth Agee in 1984. Ten years later, he joined the Company as VP of Finance and later became its President/COO. During his tenure with Syntroleum, he negotiated several partnerships, joint R&D agreements and license agreements with 7 international oil companies. He led Syntroleum’s public offering in 2000. Mr. Agee’s involvement with EFT began in 2010 where he has focused primarily on business development, strategy and licensing. He holds a degree in chemical engineering from the University of Tulsa and is listed on 10 issued U.S. patents all in the field of synthetic or renewable fuels.

 

Edwin L. Holcomb Jr., Chief Accounting Officer and Director, has eight years of public accounting and 31 years of corporate finance experience. He has held positions of VP of Finance, Chief Accounting Officer, and Controller prior to joining EFT and has over 10 years directing the SEC reporting at Docucorp International, EXE Technologies and Memorex Telex. Mr. Holcomb is a CPA and holds a BSBA degree majoring in Accounting from the University of Tulsa. 

  

Ronnie Young, Lab Manager, joined the Company from Syntroleum Corporation where he was a supervisory chemist. Mr. Young has a background in oil and gas production and farming/ranching. While earning a M.S. in Chemistry from the University of Oklahoma, Mr. Young gained applicable experience in the synthesis, handling, and characterization techniques for air and moisture sensitive materials. As the lab manager for the Company, Mr. Young continues to direct lab operations which have expanded beyond small scale to various pilot plant reactor designs and capabilities. Additionally, Mr. Young has worked to make improvements in Fischer-Tropsch catalyst formulation, preparation, and characterization methods in support of two commercial catalyst manufacturers.

 

 

 

 17 

 

 

James W. Engman, Technical Services Manager, joined the Company from Syntroleum Corporation and has spent over 20 years working in the laboratory supporting the development of FT catalyst and related process technologies. Mr. Engman has managed the catalyst development laboratory for both Syntroleum and the Company. Mr. Engman has provided technical support for both our FT reactor and catalyst development activities and our extensive hydro-processing development activities. This included developing catalyst and process parameters for production of jet, diesel, solvents and base oils. Prior to his work in the FT, Mr. Engman was the Laboratory Director for National Analytical Laboratories an environmental testing service laboratory. Mr. Engman holds a B.S. in Biochemistry from the University of Minnesota and an M.S. in Chemistry from St. Mary’s University of Texas.

 

Terry L. Ingle, Director, is the President and part owner of Mingo Manufacturing Inc. in Owasso, Oklahoma. Mr. Ingle has held that position 20 of the past 23 years. Mingo Manufacturing is an engineering and machine shop with heavy emphasis in the design and manufacture of downhole submersible and surface mounted oil pumping equipment. Mingo Manufacturing has been in business since 1981. Mr. Ingle’s main duty is to oversee the day-to-day operations of the Company. Mr. Ingle graduated from Oklahoma State University in 1978 with a Bachelor of Science degree in Mechanical Engineering Design Technology.

 

Ray L. Witten, Director, is the Vice President and part owner of Mingo Manufacturing Inc. in Owasso, Oklahoma. Mr. Witten has held that position for the last 40 years. Mingo Manufacturing is an engineering and machine shop with heavy emphasis in the design and manufacture of downhole submersible and surface mounted oil pumping equipment. Mingo Manufacturing Inc. has been in business since 1981. Mr. Witten oversees the design and production of new product lines for Mingo Manufacturing. Mr. Witten graduated from Oklahoma State University in 1979 with a Bachelor of Science degree in Mechanical Engineering Design Technology.

 

Katie M. Werner, Director, is the Director of Strategic Planning of the Black & Veatch Gas, Fuels and Chemicals Business. Ms. Werner is an Associate Vice-President at Black & Veatch who oversees operations, strategy and human resources for Black & Veatch’s global Gas, Fuels and Chemicals. Ms. Werner graduated from University of Mississippi with a Bachelor of Science degree in Civil Engineering.

 

Compensation of Directors and Executive Officers

 

For the fiscal year ended December 31, 2022 we compensated our three highest-paid directors and executive officers as follows:

 

Name  

Capacities in which

compensation was received

  

Cash

compensation

($)

    

Other

compensation

($)

    

Total

compensation

($)

  
Kenneth L. Agee   President     220,000       0       220,000  
Mark A. Agee   VP Business Development     200,000       0       200,000  
Edwin L. Holcomb Jr.   Chief Accounting Officer     125,000       0       125,000  

 

For the fiscal year ended December 31, 2022, our directors were not paid any compensation for their services as directors. There are five (5) directors in this group.

  

Each of the Company’s officers have entered into employment agreements with the Company. Under his employment agreement, Ken Agee is paid a salary of $220,000. He is eligible to receive performance bonuses. Any bonus will be based on the achievement of goals and milestones established by the Company’s board of directors. In the event that his employment is terminated other than for cause or his resignation, he is eligible to receive severance of 3 months’ salary and benefits and any amounts of compensation not yet paid at the date of termination. In the event of a change of control of the Company (as defined in the agreement), if his employment is terminated for any reason other than death, disability, retirement, just cause or Good Reason (as defined in the agreement), he is eligible to receive severance of up to 18 months’ salary. In either instance of termination, he is also eligible to be paid a pro rata portion of any bonus determined by the board of directors, in its sole discretion, to be paid to employees for the year in which the termination occurred.

 

 

 

 18 

 

 

Under his employment agreement, Mark Agee is paid a starting salary of $200,000. He is eligible to receive performance bonuses. Any bonus will be based on the achievement of goals and milestones established by the Company’s board of directors. In the event that his employment is terminated other than for cause or his resignation, he is eligible to receive severance of 3 months’ salary and benefits. In the event of a change of control of the Company (as defined in the agreement), if his employment is terminated for any reason other than death, disability, retirement, just cause or Good Reason (as defined in the agreement), he is eligible to receive severance of up to 18 months’ salary. In either instance of termination, he is also eligible to be paid a pro rata portion of any bonus determined by the board of directors, in its sole discretion, to be paid to employees for the year in which the termination occurred.

 

Under his employment agreement, Ed Holcomb is currently paid a salary of $125,000 that is not reflected in the employment agreement but agreed to between Mr. Holcomb and the Company. His salary was adjusted from $95,000 to $125,000 annually on November 12, 2021. He is eligible to receive performance bonuses. Any bonus will be based on the achievement of goals and milestones established by the Company’s board of directors. In the event that his employment is terminated other than for cause or his resignation, he is eligible to receive severance of 3 months’ salary and benefits. In the event of a change of control of the Company (as defined in the agreement), if his employment is terminated for any reason other than death, disability, retirement, just cause or Good Reason (as defined in the agreement), he is eligible to receive severance of up to 18 months’ salary. In either instance of termination, he is also eligible to be paid a pro rata portion of any bonus determined by the board of directors, in its sole discretion, to be paid to employees for the year in which the termination occurred.

 

Item 4. Security Ownership of Management and Certain Securityholders

 

The following table displays, as of March 31, 2023, the voting securities beneficially owned by (1) any individual director or officer who beneficially owns more than 10% of any class of our capital stock, (2) all executive officers and directors as a group and (3) any other holder who beneficially owns more than 10% of any class of our capital stock:

 

Title of Class  Name and address of beneficial owner  Amount and nature of beneficial ownership  

Amount and nature of beneficial ownership acquirable

(4)(5)

  

Percent of

class (1)

 
Common Stock  Kenneth L. Agee Trust of The Kenneth L. Agee Trust dated May 18, 2007 (2)
13137 South Yorktown Avenue, Bixby, OK 74008		   13,200,000.00    432,627.40    49.06% 
Common Stock  Rafael Luis Espinoza
5026 Oak Leaf Drive, Tulsa, Oklahoma 74131		   5,930,000.00         21.68% 
Common Stock  Terry Ingle
19801 E. 86th St. N., Owasso, OK 74055		   2,926,470.70    620,000.00    12.68% 
Common Stock  Ray Witten
9803 N. Newbury St., Owasso, OK 74055		   2,776,470.70    620,000.00    12.14% 
Common Stock  All current officers and directors as a group (6 people)   21,172,941.40    3,459,363.01    88.15% 
                   
Series A Preferred Stock  Black & Veatch Corporation ("B&V") (3)
11401 Lamar Ave., Overland Park, KS 66211		   3,766,588.20         100% 
                   
Series A Preferred Stock  All current officers and directors as a group (6 people)   0    0    0% 

__________________________

  (1) The final column (Percent of Class) includes a calculation of the amount the person owns now, plus the amount that person is entitled to acquire. That amount is then shown as a percentage of the outstanding number of securities in that class if no other people exercised their rights to acquire those securities. The result is a calculation of the maximum amount that person could ever own based on their current and acquirable ownership, which is why the amounts in this column will not add up to 100%.
  (2) Mr. Agee is a trustee of the trust and may be deemed to beneficially own the shares held by the trust.
  (3) Ms. Werner, an officer of B&V and a member of our board of directors who serves as B&V’s designee, does not individually own any securities of the Company and disclaims beneficial ownership of such shares held by B&V.
  (4) Does not include 500,000 and 500,000 options held by officers that will vest if the Company raises more than $15 million and $30 million, respectively, in its Regulation A offering.
  (5) Does not include 100.00 shares of Non-Voting Common Stock owned by Kenneth Agee at March 31, 2023.

  

 

 19 

 

 

Item 5. Interest of Management and Others in Certain Transactions

 

Black & Veatch Corporation:

 

B&V owns all (100%) of the Company’s Series A Preferred Stock.

 

On December 2, 2015, the Company and B&V entered into a Stock Purchase Agreement under which EFT sold the Series A Preferred Stock to B&V. Under the Stock Purchase Agreement, B&V has a put option that it may exercise at any time on or after the fifth anniversary of the agreement (or December 2, 2020). B&V can require the Company to repurchase all of the Series A Preferred Stock from B&V at a per share price based on the Company’s then-current enterprise value.

 

In May 2021, the stock purchase agreement was amended to change the put option right to any time on or after the seventh anniversary of the issuance of the shares, unless the Company does not complete a funding raise of at least $15 million on or before June 30, 2022, in which case the put option timeframe reverts back to the fifth anniversary. In addition, the term of the put option was extended from 10 years to 12 years after issuance. The Company did not raise the $15 million, therefore the put option timeframe reverted back to the fifth anniversary and the term of the put option continues to be 12 years after issuance. In addition, under the agreement, the Company must (i) pay dividends to B&V under certain circumstances and (ii) use B&V as its engineering, procurement, and construction contractor on all of the Company’s micro-GTL (BioGTL) projects under certain circumstances for a period of 5 years (or until May 11, 2026).

 

On December 2, 2015, the Company and B&V entered into the First Amended and Restated Collaboration Agreement under which (among other things and subject to other terms and conditions) (i) the Company will recommend only B&V for engineering, procurement and construction services related to projects that utilize the Company’s technology, (ii) the Company will grant to B&V the right to represent the Company’s technology on a worldwide basis and (iii) the Company will use B&V for fabrication and/or fabrication management services to provide pre-engineered truckable skids and/or modules (subject to the Company’s agreement with Mingo GTL, LLC). The term of this agreement is for a period of 10 years from the effective date (or until December 2, 2025).

 

Mingo GTL, LLC:

 

Mingo GTL, LLC (“Mingo”) is controlled by Terry Ingle and Ray Witten, each a shareholder and director of the Company. On March 11, 2016, the Company and Mingo entered into the Third Amended and Restated Manufacturing and Technical Support Agreement under which (among other things and subject to certain terms and conditions) (i) Mingo will provide certain support services to the Company pertaining to any advanced fixed bed items (including, module, reactors, or components or any assemblies or parts therefor) and (ii) Mingo will have the option to manufacture certain advanced fixed bed items (including, module, reactors, or components or any assemblies or parts therefor). The term of this agreement is for a period of 10 years following the date on which the Company provides an engagement notice to Mingo with automatic 5-year renewal terms unless terminated by either party upon 30 days’ prior written notice to the other party; provided, however, if the Company has never provided an engagement notice to Mingo, then the term of the agreement is for a period of 10 years from the effective date (or until March 11, 2026). To date, the Company has not provided an engagement notice to Mingo.

 

Item 6. Other Information

 

None

 

 

 

 

 

 20 

 

 

Item 7. Financial Statements

 

EMERGING FUELS TECHNOLOGY, Inc.

 

FINANCIAL REPORT

 

For the Years Ended

December 31, 2022 and 2021

 

 

TABLE OF CONTENTS

 

Independent Auditors’ Report 22
Balance Sheets 23
Statements of Operations 24
Statements of Changes in Stockholders’ Equity (Deficit) 25
Statements of Cash Flows 26
Notes to Financial Statements 27-37

 

 

 

 

 

 

 

 

 

 21 

 

 

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

To the Board of Directors and Stockholders of Emerging Fuel Technology, Inc.

 

Opinion on the Financial Statements

 

We have audited the accompanying balance sheet of Emerging Fuel Technology, Inc. (the Company) as of December 31, 2022 and 2021, and the related statements of operations, changes in stockholders’ equity (deficit), and cash flows for each of the years in the two- year period ended December 31, 2022, and the related notes (collectively referred to as the financial statements). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2022 and 2021, and the results of its operations and its cash flows for each of the years in the two- year period ended December 31, 2022, in conformity with accounting principles generally accepted in the United States of America.

 

Going Concern

 

The accompanying financial statements have been prepared assuming the Company will continue as a going concern. As discussed in Note 1 to the accompanying financial statements, the Company has incurred recurring losses from operations, and had an accumulated deficit that raises substantial doubt about the Company’s ability to continue as a going concern. Management’s evaluation of the events and conditions and management’s plans in regarding these matters are also described in Note 1. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

 

Basis for Opinion

 

These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s financial statements based on our audit. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

 

We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audit, we are required to obtain an understanding of internal control over financial reporting, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.

 

Our audit included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audit also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audit provides a reasonable basis for our opinion.

 

Critical Audit Matters

 

The critical audit matter communicated below is a matter arising from the current period audit of the financial statements that were communicated or required to be communicated to the audit committee and that: (1) relate to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matter does not alter in any way our opinion on the financial statements, taken as a whole, and we are not, by communicating the critical audit matters below, providing separate opinions on the critical audit matter or on the accounts or disclosures to which they relate.

 

Revenue Recognition

 

As discussed in Note 2, the Company recognizes revenue based upon satisfaction of certain performance obligations and has multiple revenue sources. Understanding when the performance obligation has been completed can sometimes require significant judgment. We tested the Company’s support for all of their material revenue sources and the timing in which the Company completed the related performance obligation.

 

We tested the Company’s allocation of transaction price and other variables that impact revenue recognition.

 

/s/ M&K CPAS, PLLC

 

www.mkacpas.com

We have served as the Company’s auditor since 2021.

Houston, Texas

April 28, 2023

 

 22 

 

 

EMERGING FUELS TECHNOLOGY, INC.

Balance Sheets

December 31, 2022 and 2021

 

 

   December   December 
   2022   2021 
ASSETS          
           
Current Assets          
Cash  $1,509,041   $1,241,735 
Accounts receivable, net   125,282    33,745 
Inventories   9,249    8,175 
Prepaid expenses   20,753    66,295 
Total current assets   1,664,325    1,349,950 
           
Property and equipment, net   86,975    114,807 
Intangible assets, net   220,444    207,237 
Operating lease asset   38,029    – 
Other assets   36,403    36,403 
           
Total assets  $2,046,176   $1,708,397 
           
LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)          
           
Current Liabilities          
Accounts payable  $160,520   $184,507 
Accrued expenses   313,914    66,464 
Operating lease liability   38,029    – 
Deferred revenue   61,625    337,850 
Short-term debt, net of discount   650,000    746,823 
Total current liabilities   1,224,088    1,335,644 
           
Deferred revenue   1,085,750    725,750 
Debt   500,000    500,000 
Total liabilities   2,809,838    2,561,394 
Commitments and Contingencies          
Preferred stock, par value $.000001 per share, 20,000,000 authorized: 3,766,588 issued and outstanding in 2022 and 2021   3,000,000    3,000,000 
Stockholders' equity (deficit)          
Common stock, par value $.000001 per share, 110,000,000 authorized: 30,073,029 issued and  27,352,941 outstanding in 2022 and 2021   32    32 
Non-Voting stock, par value $.000001 per share, 110,000,000 authorized: 234,550 and 5,898 shares issued and outstanding in 2022 and 2021, respectively   –    – 
Additional paid on capital   9,494,240    9,353,093 
Treasury stock, at cost; 2,720,088 shares   (10,000)   (10,000)
Accumulated deficit   (13,247,934)   (13,196,122)
Total stockholders' equity (deficit)   (3,763,662)   (3,852,997)
           
Total liabilities and stockholders' equity (deficit)  $2,046,176   $1,708,397 

 

See Notes to Financial Statements

 

 

 23 

 

 

EMERGING FUELS TECHNOLOGY, INC.

Statements of Operations

For the Years Ended December 31, 2022, and 2021

 

 

   December   December 
   2022   2021 
Revenue          
Lab and licensing  $1,746,950   $1,260,087 
Engineering and technical   1,170,350    396,335 
Other   88,208    26,392 
Total revenue   3,005,508    1,682,814 
           
Lab and Engineering Costs          
Payroll and benefits   441,651    436,343 
Subcontracted services   673,685    266,799 
Gas costs   141,745    162,246 
Catalyst & demo plant cost   335,757    356,189 
Other   21,054    26,327 
Total lab and engineering   1,613,892    1,247,904 
           
Operating Expenses          
Payroll and benefits   646,832    614,242 
Stock -based compensation   –    3,292 
Contract and professional services   452,482    744,731 
Rent   73,033    71,530 
Utilities   52,915    45,149 
Depreciation and amortization   46,392    43,952 
Provision for bad debt   –    263,310 
Loss on asset impairment   –    8,434 
Other   82,005    85,264 
Total operating expenses   1,353,659    1,879,904 
           
Income (loss) from operations   37,957    (1,444,994)
           
Other Income (Expense)          
Gain on forgiveness of loan   –    174,139 
Interest income (expense), net   (89,769)   (37,860)
Total other Income (expense)   (89,769)   136,279 
           
Net loss  $(51,812)  $(1,308,715)
           
Net loss per common share - basic and diluted  $(0.00)  $(0.05)
Weighted average number of common shares outstanding:          
Basic and diluted   27,451,491    27,353,518 

 

See Notes to Financial Statements

 

 

 24 

 

 

EMERGING FUELS TECHNOLOGY, INC.

Statements of Changes in Stockholders' Equity (Deficit)

For the Years Ended December 31, 2022 and 2021

 

 

       Non-Voting   Additional                 
   Common   Common   Paid-in   Treasury   Accumulated       Mezzanine 
   Stock   Stock   Capital   Stock   Deficit   Total   Equity 
                             
Balances January 1, 2021  $32   $–   $9,323,803   $(10,000)  $(11,887,407)  $(2,573,572)  $3,000,000 
                                    
Stock-Based Compensation   –    –    3,292    –    –    3,292    – 
                                    
Issuance of Warrants   –    –    4,765    –    –    4,765    – 
                                    
Issuance of Non-voting Stock   –    –    21,233    –    –    21,233    – 
                                    
Net Loss for the Year Ended December 31, 2021   –    –    –    –    (1,308,715)   (1,308,715)   – 
                                    
Balances December 31, 2021   32    –    9,353,093    (10,000)   (13,196,122)   (3,852,997)   3,000,000 
                                    
Convertible debt conversion   –    –    110,000    –    –    110,000    – 
                                    
Issuance of Non- Voting Stock   –    –    31,147    –    –    31,147    – 
                                    
Net Loss for the Year Ended December 31, 2022   –    –    –    –    (51,812)   (51,812)   – 
                                    
Balances December 31, 2022  $32   $–   $9,494,240   $(10,000)  $(13,247,934)  $(3,763,662)  $3,000,000 

 

See Notes to Financial Statements

 

 

 

 

 25 

 

 

EMERGING FUELS TECHNOLOGY, INC.

Statements of Cash Flows

For the Years Ended December 31, 2022 and 2021

 

   December   December 
   2022   2021 
Cash Flows From Operating Activities          
Net loss  $(51,812)  $(1,308,715)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:          
Provision for bad debt   –    263,310 
Gain on forgiveness of loan   –    (174,139)
Loss on asset impairment   –    8,434 
Depreciation and amortization   46,392    43,952 
Accretion of debt discount   3,177    1,588 
Stock-based compensation   –    3,292 
Changes in operating assets and liabilities:          
Accounts receivable   (91,537)   (167,164)
Inventories   (1,074)   2,564 
Prepaid expenses   45,542    (56,736)
Accounts payable   (23,987)   118,221 
Accrued expenses   257,450    8,081 
Deferred revenues   83,775    457,850 
Net cash provided by (used in) operating activities   267,926    (799,462)
           
Cash Flows From Investing Activities          
Purchase of property and equipment   (2,708)   (4,212)
Patent and trademark costs   (29,059)   (53,519)
Net cash used in investing activities   (31,767)   (57,731)
           
Cash Flows From Financing Activities          
Proceeds from convertible notes payable   –    750,000 
Proceeds from SBA loans   –    522,600 
Non-Voting stock proceeds   31,147    21,233 
    –    – 
Net cash provided by financing activities   31,147    1,293,833 
           
Increase in cash   267,306    436,640 
           
Cash and cash equivalents - beginning   1,241,735    805,095 
           
Cash and cash equivalents - ending  $1,509,041   $1,241,735 
           
           
Supplemental disclosures:          
Cash paid for operating lease  $65,806   $64,706 
Debt conversion  $110,000   $– 
Non-cash discount on debt  $–   $4,765 
Establishment of ROU asset and lease liability  $102,910   $– 
Cash paid for interest  $–   $– 

 

See Notes to Financial Statements

 

 

 26 

 

 

EMERGING FUELS TECHNOLOGY, INC.

Notes to Financial Statements

December 31, 2022 and December 31, 2021

 

 

Note 1 Summary of Significant Accounting Policies

 

Nature of Business

Emerging Fuels Technology, Inc. (the Company) is a well-established energy technology company with a research and development facility in Tulsa, Oklahoma. The Company has a growing portfolio of 33 granted or pending patents and trademarks with historic revenue from contract research, license fees and catalyst sales from multiple licensed projects at various stages of development. The Company is planning to expand its business by using its technology to build, own and operate facilities to convert waste sourced of carbon into drop-in compatible fuels and chemicals that reduce greenhouse gas.

 

Liquidity and Future Operations

Although our audited financial statements for the years ended December 31, 2022 and December 31, 2021 were prepared under the assumption that we would continue our operations as a going concern, the report of our independent registered public accounting firm that accompanies our financial statements for the years ended December 31, 2022 and December 31, 2021 contains a going concern qualification in which such firm expressed substantial doubt about our ability to continue as a going concern, based on the financial statements at that time. Specifically, the Company has incurred a net loss for the years ended December 31, 2022 and 2021, may incur additional losses in the future and has incurred cumulative operating losses since inception.

 

Management understands that the negative results are not sustainable. The Company’s ultimate success depends on the outcome of a combination of factors, including the following: (i) successful commercialization of patented technology; (ii) market acceptance and commercial viability of the Company’s technology; and (iii) ability to meet working capital needs. Management believes that there are several positive initiatives that will allow the Company to achieve its goals, including the following: (i) interest in renewable fuels has continued to increase, attributable to higher oil prices and the need for energy security; (ii) the Company has opened discussions with several large companies seeking a strategic partnership; and (iii) the Company has experienced an increased level of inquiries from project developers seeking to license its technology for biomass, municipal solid waste, and biogases to liquid fuels and CO2 to fuels projects. Additionally, the Company continues to pursue additional sources of funding, including raising funds through the issuance of common stock under its Regulation A offering.

 

Based upon the Company’s current operating plan, management expects that cash at December 31, 2022, in combination with anticipated revenue and additional sources of funding, will be sufficient to fund operations for at least the next 12 months. The Company has evaluated and will continue to evaluate its operating expenses and will concentrate its resources toward successful commercialization of its patented technology. However, there are no assurances that the Company will be successful in implementing its plan and any inability to execute the plan could have a material adverse effect on the business and its operations.

 

Basis of Accounting

The Company reports on the accrual basis of accounting which recognizes income when earned and expenses when incurred.

 

Management Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (GAAP) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

 

 

 

 27 

 

 

Concentration of Credit Risk

The Company’s financial instruments that are exposed to concentrations of credit risk consist primarily of cash and accounts receivable. The Company maintains cash in bank deposit accounts which, at times, may exceed federally insured limits. The Company has not experienced any losses in such accounts and believes that it is not exposed to any significant credit risk with respect to cash. The Company also routinely assesses the financial strength of its customers and any associated accounts receivable credit risk exposure and records a reserve if needed.

 

Cash and Cash Equivalents

The Company considers all highly liquid investments with a maturity of three months or less when purchased to be cash equivalents.

 

Accounts Receivable and Bad Debts

The Company has receivables that arise from its customer agreements. Losses from uncollectible receivables are accrued when it is probable that a receivable is impaired, and the amount of the loss can be reasonably estimated. During the year ending December 31, 2021, management determined that these conditions existed and continue to exist and, as such, an allowance for doubtful accounts was established in the amount of $263,310. This amount is related to services provided to our licensee in Trinidad and Tobago. During 2021, the licensee’s gas to liquid fuels plant experienced an adverse event during start-up that involved part of the plant not related to our technology license. The plant has been down for repairs and improvements, and it is not clear if sufficient funding will be obtained to resume operations or pay our receivables.

 

Inventories

Inventories are valued at the lower of cost (first-in, first-out method) and net realizable value. Inventories are comprised of gases used in our lab operations and can include materials and services purchased associated with projects for clients.

 

Long-Lived Assets

The Company assesses all long-lived assets, including property and equipment, for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Factors that are considered in deciding when to perform an impairment review include significant under-performance of the business in relation to expectations, significant negative industry or economic trends, and significant changes or planned changes in the use of the assets.

 

Property and Equipment

Property and equipment are recorded at cost and depreciated over the estimated useful life. When retired or otherwise disposed of, the related cost and accumulated depreciation are cleared from the respective accounts and the net difference, less any amount realized from the disposition, is reflected in income.

 

Depreciation is provided for on the straight-line method over the following estimated useful lives:

 

  Years
Lab Equipment 7
Office Furniture and Equipment 5
Computers 3

 

Patents and Trademarks

Patents and trademarks are recorded at cost less accumulated amortization and impairment losses. Amortization is charged on a straight-line basis over the lesser of 20 years from the date of filing or 17 years from the date of issuance, which is the estimated useful economic life. Useful lives are reviewed annually and adjusted if appropriate.

 

 

 

 28 

 

 

Operating Lease Asset and Liability

The company determines if an arrangement is or contains a lease at inception. The Company records a right-of-use (ROU) assets and lease obligations for our finance and operating leases, which are initially based on the discounted future minimum lease payments over the term of the lease. As the rate implicit in the leases is not easily determinable, the Company elected to use the risk-free rate for the same period of time as the lease discount rate.

 

Lease term is defined as the non-cancelable period of the lease plus any options to extend the lease when it is reasonably certain that it will be exercised. For leases with the initial term of 12 months or less, no ROU assets or lease obligations are recorded on the balance sheet and the Company recognizes lease expense for these leases on a straight-line basis over the lease term.

 

Operating lease expense is recognized on a straight-line basis over the lease term and is included in rent expense. Variable payments, short-term rentals in payments associated with non-lease components are expensed as incurred.

 

Income Taxes

Deferred income taxes are provided to reflect the impact of temporary differences between the amounts of assets and liabilities for financial reporting purposes and such amounts as measured by tax laws and regulations. Tax credits are recognized as a reduction to income taxes in the year the credits are earned.

 

Tax positions are recognized only when it is more likely than not (likelihood of greater than 50%) that the position would be sustained upon examination based solely on the technical merits of the position. Tax positions that meet the more likely than not threshold are measured using a probability-weighted approach as the largest amount of tax benefit that is greater than 50% likely of being realized upon settlement.

 

Stock-Based Compensation

The Company measures compensation cost for stock option awards at fair value and recognizes compensation over the service period for awards expected to vest. The fair value of each option grant is estimated on the date of grant using the Black-Scholes pricing model and straight-line amortization of compensation expense over the requisite service period of the grant. The determination of fair value using the Black-Scholes model requires a number of complex and subjective variables. Key assumptions in the Black-Scholes pricing model include the market value and exercise price of the options, the expected term, expected volatility, the risk-free interest rate, and estimated forfeitures.

 

Advertising

The Company expenses all advertising costs as incurred.

 

Fair Value of Financial Instruments

The carrying amounts of financial instruments, including cash and cash equivalents, accounts receivable, accounts payable, and debt borrowings approximates fair value due to the nature and maturity of these instruments.

 

Earnings Per Share

Basic earnings per share is calculated using the weighted-average number of shares of common stock outstanding during the period. Diluted earnings per share calculations include any dilutive effect of potential common shares. The computation of diluted earnings per share for the years ended December 31, 2022 and 2021 excluded the impact of the assumed conversion of the Series A preferred stock and convertible notes, and the assumed exercise of warrants and stock options, because they would have been anti-dilutive. The earnings per share data presented in the statements of operations for the year ended December 31, 2021 reflects the effect of the 10,000 to 1 stock split approved in July 2021 (see Note 8).

 

 

 

 29 

 

 

Recent Accounting Pronouncements

In February 2016, the Financial Accounting Standards Board issued Accounting Standards Update (ASU) No. 2016-02, Leases (Topic 842), which establishes new accounting and disclosure requirements for leases. This ASU requires lessees to classify most leases as either finance or operating leases and to initially recognize a lease liability and right-of-use asset (ROU). Entities may elect to account for certain short-term leases (with a term of 12 months or less) using a method similar to the current operating lease model. The Company adopted ASU No. 2016-02 effective January 1, 2022 using the modified retrospective approach. The adoption of this guidance resulted in a $102,910 increase in total assets and liabilities as of January 1, 2022, as the Company recognized an operating lease ROU asset and a corresponding operating lease obligation.

 

In August 2020, the FASB issued ASU 2020-06, ASC Subtopic 470-20 “Debt—Debt with Conversion and Other Options”. The standard reduced the number of accounting models for convertible debt instruments and convertible preferred stock. Convertible instruments that continue to be subject to separation models are (1) those with embedded conversion features that are not clearly and closely related to the host contract, that meet the definition of a derivative, and that do not qualify for a scope exception from derivative accounting; and, (2) convertible debt instruments issued with substantial premiums for which the premiums are recorded as paid-in capital. The amendments in this update are effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. The Company adopted this guidance for the year ended December 31, 2021 concurrent with issuance of convertible debt.

 

Note 2 Revenue Recognition

 

The Company generates revenue through contracts in which it (i) sells Fischer-Tropsch and ammonia oxidation catalysts, (ii) provides technology license agreements and (iii) performs lab and engineering services. In general, contracts with the Company provide a license agreement for the use of its intellectual property and catalyst technology, over which the Company holds a significant number of patents. The majority of the Company’s revenue is derived from a small number of significant commercial customers. Revenue is recognized when the Company satisfies a performance obligation by transferring promised goods or services to a customer. Revenue from goods or services is measured as the amount of consideration expected to be received in exchange for the goods and services delivered.

 

The Company’s licensing agreements provide for the transfer of licensing rights to proprietary technology, which is considered functional intellectual property. The licensing agreements provide for a prepaid royalty along with ongoing royalties based on output. The prepaid royalty is recognized upon execution of the licensing agreement or based on the timeline specified in the agreement. Typically, the licensing agreements contain a process guarantee to the licensee, which provides that the Company guarantees the output of 100% of the plant design capacity as long as the licensee satisfies certain operational requirements. Failure to achieve the guaranteed output may require the Company to repay a portion of the prepaid royalty based on the percent of design capacity achieved. As such, the Company defers recognition of a portion of the prepaid royalty until resolution of the process guarantee. The revenue generated by sales of the catalyst is based on a mark-up of the catalyst costs paid to approved catalyst vendors and recognized as obligations are satisfied by those vendors. During 2021, the Company began selling ammonia oxidation catalyst to customers. The Company acquires this catalyst from a vendor and recognizes revenue and costs of the catalyst, and revenue sharing marketing costs, upon delivery to the customer. Revenue from lab and engineering services is earned on a time and materials or percent complete basis and is recognized as the work is performed. Consideration received prior to satisfying the related performance obligations is recorded as deferred revenue and revenue will be recognized when the obligations have been met.

 

 

 

 30 

 

 

Note 3 Property and Equipment

 

Property and equipment consisted of the following at December 31:

 

   December 31,   December 31, 
   2022   2021 
         
Lab Equipment  $775,658   $773,443 
Office Furniture and Equipment   108,295    108,295 
Computers   26,846    26,353 
    910,799    908,091 
Less: Accumulated Depreciation   (823,824)   (793,284)
           
Property and Equipment, Net  $86,975   $114,807 

 

Depreciation expense amounted to $30,540 and $29,899 for the years ended December 31, 2022 and 2021, respectively.

 

Note 4 Intangible Assets

 

Intangible assets consisted of the following at December 31:

 

   December 31,   December 31, 
   2022   2021 
         
Patents and Trademarks  $294,420   $265,361 
Less: Accumulated Amortization   (73,976)   (58,124)
           
Intangible Assets, Net  $220,444   $207,237 

 

Amortization expense amounted to $15,852 and $14,053 for the years ended December 31, 2022 and 2021, respectively. Amortization expense for each of the next five years will be approximately $17,300. An impairment loss in the amount of $8,434 was recognized in 2021 for unamortized costs associated with the abandonment of a patent project.

 

Note 5 Debt

 

On September 3, 2020, the Company entered into a loan authorization and agreement in the amount of $150,000 with the United States Small Business Administration (SBA), as lender, pursuant to the SBA’s Economic Injury Disaster Loan (EIDL) assistance program in light of the impact of the COVID-19 pandemic on the Company’s business. Borrowings under this loan bear interest at 3.75% per annum. The loan is secured by a security interest on all of the Company’s assets. Under this loan, the Company is required to make monthly principal and interest payments of $732 commencing March 2023 and are applied first to any interest accruing during the repayment deferral period. All remaining principal and accrued interest is due and payable September 2050. The loan may be repaid at any time without penalty.

 

On August 2, 2021, the Company’s EIDL loan was modified to increase the borrowings under the loan from $150,000 to $500,000. As a result of this modification, the monthly principal and interest payment was increased to $2,534. All other terms remain unchanged. As of December 31, 2022, accrued interest on this loan amounted to $31,372.

 

 

 

 31 

 

 

Estimated maturities on the above obligation are as follows:

 

December 31, 2023  $ – 
  2024    – 
  2025    – 
  2026   10,295 
  2027   12,256 
  Thereafter   477,449 
        
     $500,000 

 

In January 2021, the Company applied for and received a Second Draw loan through the Paycheck Protection Program (PPP) under the CARES Act in the amount of $172,600. The loan bears interest at a rate of 1% annually. The Company applied for forgiveness of the entire principal amount, plus accrued interest, with the SBA and the SBA granted forgiveness of the loan and all accrued interest in December 2021.

 

 In August 2021, the Company issued $750,000 of convertible notes. The notes were due and payable in full on the first anniversary of the execution date and bear interest at 10% per annum.

 

In August 2022, $650,000 of the convertible notes were extended and now are due and payable in full on the second anniversary of the execution date. In addition, $100,000 of the convertible notes elected to convert principal and interest of $10,000 into 220,000 shares of non-voting common stock shares.

 

At any time prior to payment in full of the outstanding principal balance and accrued interest, the holder of the convertible note may convert the principal and interest into shares of non-voting common stock at a conversion price of $0.50 per share.

 

In connection with this issuance, the Company issued stock warrants to purchase 1,500,000 shares of non-voting common stock at a price of $0.50 per share. The warrants expire ten years from the date of issuance. When warrants are issued in connection with debt, GAAP requires the proceeds from the debt issuance to be allocated between the debt and the warrants based on their relative fair values. The Company estimated the fair value of the convertible notes based on a comparison to the interest rate for similar notes issued without warrants. The fair value of the warrants was estimated on the grant date using the Black-Scholes valuation model and the following key assumptions:

 

Expected stock price volatility 34.00%
Risk-free interest rate 1.29%
Exercise price $0.50

 

Expected volatility is based on historical volatility of the stock for comparable companies in the renewable energy sector. The risk-free interest rate is based on the grant date projected yield for a U.S. Treasury bond with a maturity date closest to the term of the warrant.

 

This resulted in $4,765 being allocated to the warrants, which was recorded as debt discount and will be amortized over the term of the convertible notes. Amortization of debt discount amounted to $3,177 and $1,588 for the years ended December 31, 2022 and 2021, respectively, and is included in interest expense on the Statements of Operations. As of December 31, 2022, accrued interest on these notes amounted to $90,006.

 

Note 6 Income Taxes

 

The current tax expense relates to state taxes. The differences between income taxes computed using the statutory U.S. federal income tax rate and the effective rate is primarily due to state taxes and the effect of the valuation allowance.

 

 

 

 32 

 

 

The tax effects of temporary differences that give rise to significant portions of the deferred tax assets and liabilities as of December 31 are as follows:

 

   December 31,   December 31, 
   2022   2021 
Depreciation  $(21,496)  $(23,558)
Stock-Based Compensation   161,207    171,750 
Patents   (53,259)   (53,343)
Deferred Revenue   262,317    155,920 
Net Operating Losses   2,718,747    2,985,443 
    3,067,516    3,236,212 
Valuation Allowance   (3,067,516)   (3,236,212)
           
Net Noncurrent Deferred Tax Asset  $–   $– 

 

The Company has performed the required assessment of positive and negative evidence regarding the realization of deferred tax assets. This assessment included the evaluation of scheduled reversals of deferred income tax assets and liabilities and estimates of projected future taxable income.

 

In assessing the realizability of deferred tax assets, the Company considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Based on the Company’s historical net losses, management did not believe that it was more likely than not that the Company would realize the benefits of these deferred tax assets as of December 31, 2022 and 2021 and, accordingly, a full valuation allowance was recorded against the deferred tax assets.

 

As of December 31, 2022, the Company has federal and state net operating loss carryforwards of approximately $11.3 million to offset future taxable income, which expire beginning in 2031.

 

The Company files a U.S. federal income tax return for which the statute of limitations remains open for the 2019 tax year and beyond. U.S. state jurisdictions have statutes of limitations ranging from 3 to 6 years.

 

Note 7 Stock Option Plan

 

The Company has an equity award plan (the Plan), which allows for the grant of equity-based compensation awards to management, key employees and non-employee directors. Under the Plan, the Company is authorized to grant up to 7,030,000 equity awards. The Company has issued stock options under the Plan which contain certain vesting requirements based on service or the achievement of certain performance goals.

 

During 2021, performance-based stock options to acquire 1,200,000 shares of common stock at a per share exercise price of $0.5045 were granted to two members of management. These options vest based on the achievement of certain financing goals. The fair value of these options on the date of grant was estimated at approximately $19,800 using the Black-Scholes option pricing model and the following key assumptions:

 

Expected stock price volatility 34.00%
Risk-free interest rate 0.53%
Expected life of options 4 years

 

 

 

 33 

 

 

Expected volatility is based on historical volatility of the stock for comparable companies in the renewable energy sector. The risk-free interest rate is based on the grant date projected yield for a U.S. Treasury bond with a maturity date closest to the expected life of the option.

 

There were no equity awards during 2022.

 

There were 2,670,000 stock options outstanding as of December 31, 2022 with a weighted-average exercise price per share of $0.70 and a weighted-average remaining contractual life of 4.13 years. Stock options exercisable as of December 31, 2022 were 1,670,000 with a weighted-average exercise per share of $0.81 and a weighted-average remaining contractual life of 1.49 years.

 

There were 2,670,000 stock options outstanding as of December 31, 2021 with a weighted-average exercise price per share of $0.70 and a weighted-average remaining contractual life of 5.13 years. Stock options exercisable as of December 31, 2021 were 1,670,000 with a weighted-average exercise per share of $0.81 and a weighted-average remaining contractual life of 2.49 years.

 

Note 8 Equity

 

On July 20, 2021, the Company effected a 10,000 to 1 stock split of its common stock and preferred stock. On the effective date of the stock split, (i) each share of common and preferred stock was increased to 10,000 shares; (ii) the number of shares of common stock into which each outstanding warrant or stock option to purchase common stock is exercisable were proportionately increased on a 10,000 to 1 basis; and (iii) the exercise price of each outstanding warrant or option to purchase common stock were proportionately decreased on a 1 to 10,000 basis.

 

On July 20, 2021, the Company approved the following matters: (a) the number of authorized shares of common stock was increased to 110,000,000; (b) the number of authorized shares of preferred stock was increased to 20,000,000; (c) a new class of non-voting common stock was approved with authorized shares equal to 110,000,000. The non-voting common stock will automatically convert into shares of common stock, on a one-to-one basis, upon the earliest of (i) the closing of a public stock offering of common stock, (ii) the closing of a merger, reverse merger or consolidation between the Company and another entity in which the surviving entity’s common stock is registered under the Securities Act of 1933, or (iii) agreement of the holders of a majority of the issued and outstanding common stock and Series A Convertible Participating Preferred Stock (Series A Stock).

 

In August 2021, the Company filed an offering statement on Form 1-A under Regulation A of the Securities Act pursuant to which the Company intends to offer up to 20,833,333 shares of non-voting common stock at a price of $3.60 per share. The offering commenced on September 17, 2021. The Company filed a post-qualification amendment to the offering statement on September 12, 2022 to extend the offering for another year; the amendment was qualified on September 19, 2022. During 2021 and 2022, proceeds from this offering were $21,233 and $31,147, respectively.

 

Preferred Stock

The Company entered into a stock purchase agreement dated December 2, 2015, whereby the Company issued 3,766,588.2 shares of Series A Stock, par value $0.000001 per share, for a purchase price of $3,000,000 or $0.796477 per share.

 

The stock purchase agreement provided that the shareholder shall have the right to require the Company to repurchase all or a portion of its Series A shares at any time on or after the fifth anniversary of the issuance of the shares. This put option originally terminated no later than 10 years after issuance. In May 2021, the stock purchase agreement was amended to change the put option right to any time on or after the seventh anniversary of the issuance of the shares, unless the Company does not complete a funding raise of at least $15 million on or before June 30, 2022, in which case the put option timeframe reverts back to the fifth anniversary. In addition, the term of the put option was extended from 10 years to 12 years after issuance. The Company did not raise the $15 million, therefore the put option timeframe reverted back to the fifth anniversary and the term of the put option continues to be 12 years after issuance.

 

 

 

 34 

 

 

The holders of the Series A Stock are entitled to receive dividends, if and when declared payable. No dividends shall be paid or declared on shares of common stock or any other shares of preferred stock having preferential rights to dividends ranking junior to the rights of the Series A Stock until the holders of shares of Series A Stock have been paid a cumulative per share amount in dividends equal to the original per share purchase price.

 

In connection with the May 2021 amendment, the Company agreed to pay to the Series A shareholder a dividend of 30% of the unencumbered royalties, as defined. This dividend will cease upon the earlier of the following: (i) payment of cumulative dividends equal to the original purchase price, (ii) the termination of the put option, (iii) the conversion of all Series A shares to shares of common stock. As of December 31, 2022, there are no amounts due under this arrangement.

 

In the case of liquidation, before any payment is made to the holders of shares of common stock, the holders of shares of the Series A Stock shall be entitled to receive the original per share purchase price less cumulative paid dividends. Any residual assets will be shared ratably between the holders of the Series A Stock, common stockholders, and any other series of preferred stock.

 

The holders of the Series A Stock shall have the right to convert the shares into common stock at a rate of one-to-one. Holders of the Series A Stock shall be entitled to a Board seat and shall have the right to vote on all matters submitted to a vote of shareholders and shall be entitled to that number of votes equal to the number of shares of common stock into which such holder’s shares of Series A Stock could be converted.

 

The Series A preferred stock shares are accounted for outside of permanent equity due to the terms of the repurchase provision of the preferred stock.

 

The following table summarizes the shares of stock issued as of December 31:

 

       Non-Voting     
   Common Stock   Common Stock   Preferred Stock 
             
Shares at December 31, 2021   30,073,029    5,898    3,766,588 
                
Issued   –    228,652    – 
                
Shares at December 31, 2022   30,073,029    234,550    3,766,588 

 

Note 9 Related Party and Catalyst Sale Transactions

 

During 2020, a former shareholder and customer of the Company liquidated its business under Chapter 7 of the U.S. Bankruptcy Code. In connection with this liquidation, the Company repurchased 2,720,087 shares of the Company’s common stock held by the former shareholder for a purchase price of $10,000, which was agreed to by the bankruptcy trustee. The stock is held in treasury, with shares presented on the balance sheet and statements of changes in stockholders’ equity (deficit) on a post-split basis and is reported at cost on the balance sheet. In addition, the Company agreed to take possession of catalyst owned by the former shareholder and customer and assist with identifying buyers for that catalyst. The Company and the bankruptcy trustee agreed to share any proceeds remaining, after payments to suppliers. In 2022, the Company entered into agreements with a buyer, and the bankruptcy trustee, for the sale of this EFT proprietary catalyst owned by a former shareholder and customer. The catalyst sales price was $4.2 million and after payments to suppliers of $850,000, and the shared proceeds with the bankruptcy trustee, the Company recognized income of $1,625,000 for proceeds received when the catalyst was delivered to the buyer. (See Note 14)

 

During 2021, the Company paid approximately $81,000 to the preferred stockholder for certain engineering services.

 

 

 

 35 

 

 

Note 10 Warrants

 

The Company issued stock purchase warrants in connection with the issuance of the convertible notes during 2021. The warrants entitle the holders to purchase 1,500,000 shares of non-voting common stock at an exercise price per share of $0.50. As of December 31, 2022, all warrants remain outstanding. The warrants expire in 2031 (See Note 5).

 

The Company issued stock purchase warrants to certain shareholders in connection with the sale of common and preferred stock. The warrants entitle the holder to purchase shares of common stock at a price per share specified in the warrant agreement. As of December 31, 2022 and 2021, warrants to purchase 1,240,000 shares of common stock were outstanding with a weighted-average exercise price per share of $1.30. The warrants expire in 2024.

 

Note 11 Major Customers

 

During the year ended December 31, 2022, approximately 67% of the Company’s revenue was derived from one customer. As of December 31, 2022, accounts receivable from this customer was approximately $50,000. During the year ended December 31, 2021, approximately 75% of the Company’s revenue was derived from three customers. As of December 31, 2021, accounts receivable from these customers totaled approximately $21,500. 

 

Note 12 Operating Lease

 

The Company leases its Tulsa, Oklahoma facility, which requires monthly rent payments through July 31, 2023. In addition, the Company has other month-to-month leases for storage facilities.

 

Future maturities of our lease liability as of December 31, 2022, are as follows:

 

Total undiscounted lease obligation  $38,101 
      
Less imputed interest   (72)
      
Net lease obligations  $38,029 

 

Note 13 Retirement Plan

 

The Company sponsors a defined contribution plan (the Plan) designed to meet the requirements of Section 401(k) of the Internal Revenue Code. The Plan is subject to the provisions of the Employee Retirement Income Security Act of 1974 (ERISA) and covers substantially all of its employees. Employees who are eligible to participate in the Plan are able to make employee contributions. There were no employer contributions to the Plan during the years ended December 31, 2022 and 2021.

 

Note 14 Commitments and Contingencies

 

In 2022, the Company and the buyer in the catalyst sales transaction (see Note 9) entered into a separate letter agreement whereby the Company would purchase seven metric tons of catalyst from the buyer for approximately $700,000. Additionally, this agreement provides that if the Company and the buyer have not entered into a mutually agreeable definitive documentation for a site license agreement within six months of the catalyst sale, the buyer can request (1 ) the Company to use its best efforts to acquire the catalyst originally purchased by the buyer at the price paid by the buyer and (2) if the Company is unable to repurchase the catalyst, the Company will use its best efforts to arrange for a sale of the catalyst to another licensee of the Company.

 

 

 

 36 

 

 

In the normal course of business, the Company may be involved in legal proceedings, claims and assessments arising in the ordinary course of business. Such matters are subject to many uncertainties, and outcomes are not predictable with assurance. In the opinion of management, the ultimate disposition of these matters will not have a material adverse effect on the Company’s financial position or results of operations.

 

Note 15 Subsequent Events

 

On April 13, 2023, the Company and Twelve Benefit Corporation (“Twelve”) entered into the First Amended and Restated Master License Agreement under which, among other things, the Company granted Twelve access to the Company’s proprietary technology for sustainable aviation fuel utilizing our Fischer-Tropsch synthesis and Maxx Jet™ upgrading technology, subject to certain terms and conditions.  To date, the Company has received $1 million from Twelve under this agreement.

 

In preparing the financial statements, the Company has evaluated events and transactions for potential recognition or disclosure through April 28, 2023, the date that the financial statements were available to be issued.

 

 

 

 

 

 

 

 

 

 

 

 37 

 

 

Item 8. Exhibits

 

The documents listed in the Exhibit Index of this report are incorporated by reference or are filed with this report, in each case as indicated below.

 

2.1 Second Amended and Restated Certificate of Incorporation, as amended *
   
2.2 Bylaws *
   
3.1 Sixth Amended and Restated Shareholders Agreement **
   
3.2 Stock Purchase Agreement dated December 2, 2015, as amended **
   
3.3 Amendment No. 1 to Sixth Amended and Restated Shareholders Agreement, dated as of October 28, 2021 ****
   
4 Form of Subscription Agreement *
   
6.1 Broker Agreement with Dalmore Group, LLC **
   
6.2 Employment Agreement of Kenneth Agee **
   
6.3 Employment Agreement of Mark Agee **
   
6.4 Employment Agreement of Edwin Holcomb **
   
6.5 2013 Equity Award Plan, as amended **
   
6.6 Amendment to Broker-Dealer Agreement, dated January 4, 2022 ****
   
8 Form of Escrow Agreement *
   

_________________

* Incorporated by reference to the Company’s Form 1-A/A filed with the SEC on September 10, 2021.
** Incorporated by reference to the Company’s Form 1-A filed with the SEC on August 2, 2021.
*** Incorporated by reference to the Company’s Current Report on Form 1-U dated October 28, 2021.
**** Incorporated by reference to the Company’s Current Report on Form 1-U dated January 4, 2022.

 

 

 

 

 

 

 

 

 

 38 

 

 

SIGNATURES

 

Pursuant to the requirements of Regulation A, the issuer has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

    EMERGING FUELS TECHNOLOGY, INC.
     
    /s/  Kenneth L. Agee
    Kenneth L. Agee, President
    Date: April 28, 2023

 

Pursuant to the requirements of Regulation A, this report has been signed below by the following persons on behalf of the issuer and in the capacities and on the dates indicated.

 

/s/  Kenneth L. Agee  
 Kenneth L. Agee, President and Director
Date: April 28, 2023  
   
   
/s/ Edwin L. Holcomb, Jr.   
Edwin L. Holcomb, Jr., Chief Accounting Officer, principal financial officer and Director  
Date: April 28, 2023  
   
   
/s/ Terry L. Ingle  
Terry L. Ingle, Director  
Date: April 28, 2023  
   
   
/s/ Raymond L. Witten  
Raymond L. Witten, Director  
Date: April 28, 2023  
   
   
/s/ Katie M. Werner  
Katie M. Werner, Director  
Date: April 28, 2023  

 

 

 

 

 

 39